Myelin Formation

Overview

flowchart TD
    MYELIN["MYELIN"] -->|"activates"| Neurodegeneration["Neurodegeneration"]
    MYELIN["MYELIN"] -->|"activates"| Inflammation["Inflammation"]
    MYELIN["MYELIN"] -->|"activates"| Als["Als"]
    MYELIN["MYELIN"] -->|"activates"| MICROGLIA["MICROGLIA"]
    MYELIN["MYELIN"] -->|"activates"| ASTROCYTE["ASTROCYTE"]
    MYELIN["MYELIN"] -->|"activates"| Alzheimer["Alzheimer"]
    MYELIN["MYELIN"] -->|"associated with"| Als["Als"]
    MYELIN["MYELIN"] -->|"therapeutic target"| Multiple_Sclerosis["Multiple Sclerosis"]
    MYELIN["MYELIN"] -->|"activates"| NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"]
    MYELIN["MYELIN"] -->|"associated with"| MICROGLIA["MICROGLIA"]
    MYELIN["MYELIN"] -->|"activates"| OLIGODENDROCYTE["OLIGODENDROCYTE"]
    MYELIN["MYELIN"] -->|"associated with"| Multiple_Sclerosis["Multiple Sclerosis"]
    MYELIN["MYELIN"] -->|"activates"| Tumor["Tumor"]
    MYELIN["MYELIN"] -->|"activates"| Neuroinflammation["Neuroinflammation"]
    style myelin fill:#4fc3f7,stroke:#333,color:#000

Myelin formation is the process by which oligodendrocytes (in the CNS) and Schwann cells (in the PNS) wrap neuronal axons with a multi-layered lipid-rich membrane. This process is essential for rapid saltatory conduction of action potentials and provides metabolic support to axons. Dysregulation of myelin formation and maintenance is implicated in various neurodegenerative diseases including multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis ^{1Nave KA, Myelin biology and disease (2023)2023 · PMID 37543518Open reference}.

Cellular Components

Oligodendrocytes (CNS)

Oligodendrocytes are the myelin-forming cells in the central nervous system:

• Progenitor cells (OPCs): NG2-positive cells that proliferate and differentiate into mature oligodendrocytes ^{2Nishiyama A, NG2 cells (2009)2009 · PMID 19369814Open reference}

• Mature oligodendrocytes: Myelinating cells expressing PLP (proteolipid protein), MBP (myelin basic protein), and MOG (myelin oligodendrocyte glycoprotein) ^{3Baumann N, Myelin proteins (2001)2001 · PMID 11224452Open reference}

• Myelination capacity: Single oligodendrocyte can myelinate up to 60 axon segments ^{4Sherman DL, Oligodendrocyte function (2005)2005 · PMID 15897680Open reference}

Schwann Cells (PNS)

Schwann cells myelinate peripheral nerve fibers:

• Myelinating Schwann cells: Wrap larger diameter axons (>1μm) with compact myelin ^{5Jessen KR, Schwann cells (2015)2015 · PMID 26245153Open reference}

• Non-myelinating Schwann cells: Support Remak bundles of small unmyelinated axons ^{5Jessen KR, Schwann cells (2015)2015 · PMID 26245153Open reference}

• Repair Schwann cells: Dedifferentiated cells that support nerve regeneration ^{6Arthur-Farraj PJ, Repair Schwann cells (2012)2012 · PMID 22659447Open reference}

Molecular Mechanisms

Myelin Basic Protein (MBP)

MBP is the major protein component of CNS myelin:

• Function: Provides the structural framework for myelin compaction ^{7Boggs JM, MBP function (2008)2008 · PMID 18629633Open reference}

• Post-translational modifications: Phosphorylation, citrullination affect protein function ^{8Harauz G, MBP modifications (2009)2009 · PMID 19153879Open reference}

• Localization: Cytoplasmic surface of myelin membrane ^{9Bates IR, MBP localization (2002)2002 · PMID 12427658Open reference}

• Diseases: Mutations cause Pelizaeus-Merzbacher disease ^{2Nishiyama A, NG2 cells (2009)2009 · PMID 19369814Open reference}0

Proteolipid Protein (PLP)

PLP and its isoform DM20 are abundant CNS myelin proteins:

• Function: Stabilize myelin structure and oligodendrocyte survival ^{2Nishiyama A, NG2 cells (2009)2009 · PMID 19369814Open reference}1

• Topology: Tetraspan protein spanning the myelin membrane ^{2Nishiyama A, NG2 cells (2009)2009 · PMID 19369814Open reference}2

• Mutations: Cause Pelizaeus-Merzbacher disease (X-linked) ^{2Nishiyama A, NG2 cells (2009)2009 · PMID 19369814Open reference}3

Myelin Regulatory Factor (MYRF)

MYRF is a transcription factor essential for myelination:

• Function: Regulates expression of myelin genes (MBP, PLP, MAG) ^{2Nishiyama A, NG2 cells (2009)2009 · PMID 19369814Open reference}4

• Auto-cleavage: Self-cleaving transcription factor activated by cholesterol ^{2Nishiyama A, NG2 cells (2009)2009 · PMID 19369814Open reference}5

• Requirement: Essential for oligodendrocyte differentiation ^{2Nishiyama A, NG2 cells (2009)2009 · PMID 19369814Open reference}6

Other Key Proteins

Signaling Pathways

PDGF Signaling

• PDGF-AA promotes OPC proliferation via PDGFRα ^{3Baumann N, Myelin proteins (2001)2001 · PMID 11224452Open reference}1

• PDGF-BB attracts OPCs to axon segments ^{3Baumann N, Myelin proteins (2001)2001 · PMID 11224452Open reference}2

• Dysregulation leads to hypomyelination ^{3Baumann N, Myelin proteins (2001)2001 · PMID 11224452Open reference}3

Thyroid Hormone Signaling

• T3 (triiodothyronine) is essential for oligodendrocyte differentiation ^{3Baumann N, Myelin proteins (2001)2001 · PMID 11224452Open reference}4

• T3 receptor mutants cause hypothyroidism and hypomyelination ^{3Baumann N, Myelin proteins (2001)2001 · PMID 11224452Open reference}5

• Thyroid hormone response elements in MBP and PLP promoters ^{3Baumann N, Myelin proteins (2001)2001 · PMID 11224452Open reference}6

Wnt/β-Catenin Pathway

• Wnt signaling inhibits OPC differentiation temporally ^{3Baumann N, Myelin proteins (2001)2001 · PMID 11224452Open reference}7

• β-catenin levels regulate myelination timing ^{3Baumann N, Myelin proteins (2001)2001 · PMID 11224452Open reference}8

• Dysregulation implicated in demyelinating diseases ^{3Baumann N, Myelin proteins (2001)2001 · PMID 11224452Open reference}9

Cholesterol Biosynthesis

• Cholesterol is essential for myelin membrane formation ^{4Sherman DL, Oligodendrocyte function (2005)2005 · PMID 15897680Open reference}0

• LXR agonists promote myelination ^{4Sherman DL, Oligodendrocyte function (2005)2005 · PMID 15897680Open reference}1

• Demyelination reduces cholesterol synthesis ^{4Sherman DL, Oligodendrocyte function (2005)2005 · PMID 15897680Open reference}2

Myelin Assembly Process

Step 1: Axon Recognition

• Neurexin-Neuroligin interactions initiate axon-glial contact ^{4Sherman DL, Oligodendrocyte function (2005)2005 · PMID 15897680Open reference}3

• TAG-1 and L1CAM mediate initial adhesion ^{4Sherman DL, Oligodendrocyte function (2005)2005 · PMID 15897680Open reference}4

• Galactocerebroside on oligodendrocyte surface binds axonal receptors ^{4Sherman DL, Oligodendrocyte function (2005)2005 · PMID 15897680Open reference}5

Step 2: Membrane Extension

• Cytoskeletal reorganization drives membrane sheet extension ^{4Sherman DL, Oligodendrocyte function (2005)2005 · PMID 15897680Open reference}6

• Actin polymerization at leading edge ^{4Sherman DL, Oligodendrocyte function (2005)2005 · PMID 15897680Open reference}7

• Microtubule network supports membrane trafficking ^{4Sherman DL, Oligodendrocyte function (2005)2005 · PMID 15897680Open reference}8

Step 3: Myelin Wrapping

• MBP localizes to cytoplasmic channels ^{4Sherman DL, Oligodendrocyte function (2005)2005 · PMID 15897680Open reference}9

• PLP traffics via Golgi-dependent pathway ^{5Jessen KR, Schwann cells (2015)2015 · PMID 26245153Open reference}0

• Compaction removes cytoplasmic layers ^{5Jessen KR, Schwann cells (2015)2015 · PMID 26245153Open reference}1

Step 4: Radial and Longitudinal Growth

• MLC phosphorylation regulates water flux ^{5Jessen KR, Schwann cells (2015)2015 · PMID 26245153Open reference}2

• Neurofilament phosphorylation increases axon diameter ^{5Jessen KR, Schwann cells (2015)2015 · PMID 26245153Open reference}3

• Internodal length increases with maturation ^{5Jessen KR, Schwann cells (2015)2015 · PMID 26245153Open reference}4

Role in Neurodegeneration

Alzheimer’s Disease

• White matter lesions common in AD brains ^{5Jessen KR, Schwann cells (2015)2015 · PMID 26245153Open reference}5

• Oligodendrocyte dysfunction contributes to Aβ accumulation ^{5Jessen KR, Schwann cells (2015)2015 · PMID 26245153Open reference}6

• Myelin breakdown products found in amyloid plaques ^{5Jessen KR, Schwann cells (2015)2015 · PMID 26245153Open reference}7

• Widespread demyelination correlates with cognitive decline ^{5Jessen KR, Schwann cells (2015)2015 · PMID 26245153Open reference}8

Parkinson’s Disease

• Oligodendrocyte loss in substantia nigra ^{5Jessen KR, Schwann cells (2015)2015 · PMID 26245153Open reference}9

• Myelin abnormalities detected in PD white matter ^{5Jessen KR, Schwann cells (2015)2015 · PMID 26245153Open reference}0

• α-synuclein can be internal oligodendrocytes ^{5Jessen KR, Schwann cells (2015)2015 · PMID 26245153Open reference}1

• GBA mutations affect oligodendrocyte function ^{5Jessen KR, Schwann cells (2015)2015 · PMID 26245153Open reference}2

Amyotrophic Lateral Sclerosis

• Oligodendrocyte degeneration precedes motor neuron loss ^{5Jessen KR, Schwann cells (2015)2015 · PMID 26245153Open reference}3

• Reduced MBP in motor cortex ^{5Jessen KR, Schwann cells (2015)2015 · PMID 26245153Open reference}4

• OPC dysfunction in ALS models ^{5Jessen KR, Schwann cells (2015)2015 · PMID 26245153Open reference}5

• Energy support failure from oligodendrocytes ^{5Jessen KR, Schwann cells (2015)2015 · PMID 26245153Open reference}6

Multiple Sclerosis

• Autoimmune demyelination is the primary pathology ^{5Jessen KR, Schwann cells (2015)2015 · PMID 26245153Open reference}7

• Remyelination failure leads to permanent disability ^{5Jessen KR, Schwann cells (2015)2015 · PMID 26245153Open reference}8

• OPCs become senescent in chronic lesions ^{5Jessen KR, Schwann cells (2015)2015 · PMID 26245153Open reference}9

• Therapies target both immune modulation and repair ^{6Arthur-Farraj PJ, Repair Schwann cells (2012)2012 · PMID 22659447Open reference}0

Therapeutic Strategies

Promoting Remyelination

1. Lingo-1 antagonists: Anti-Lingo-1 antibody (opicinumab) in trials ^{6Arthur-Farraj PJ, Repair Schwann cells (2012)2012 · PMID 22659447Open reference}1

2. mTOR activators: Promoting OPC differentiation ^{6Arthur-Farraj PJ, Repair Schwann cells (2012)2012 · PMID 22659447Open reference}2

3. cAMP elevation: Rolipram enhances remyelination ^{6Arthur-Farraj PJ, Repair Schwann cells (2012)2012 · PMID 22659447Open reference}3

4. Statins: Cholesterol-independent remyelination effects ^{6Arthur-Farraj PJ, Repair Schwann cells (2012)2012 · PMID 22659447Open reference}4

Neuroprotective Approaches

• Bexarotene: LXR agonist promoting myelination ^{6Arthur-Farraj PJ, Repair Schwann cells (2012)2012 · PMID 22659447Open reference}5

• Clemastine: Antihistamine promoting OPC differentiation ^{6Arthur-Farraj PJ, Repair Schwann cells (2012)2012 · PMID 22659447Open reference}6

• Miconazole: Steroid promoting remyelination ^{6Arthur-Farraj PJ, Repair Schwann cells (2012)2012 · PMID 22659447Open reference}7

Cell-Based Therapies

• OPC transplantation: Clinical trials in MS patients ^{6Arthur-Farraj PJ, Repair Schwann cells (2012)2012 · PMID 22659447Open reference}8

• iPSC-derived oligodendrocytes: Potential cell therapy ^{6Arthur-Farraj PJ, Repair Schwann cells (2012)2012 · PMID 22659447Open reference}9

• Schwann cell transplantation: For PNS repair ^{7Boggs JM, MBP function (2008)2008 · PMID 18629633Open reference}0

Research Directions (2024-2026)

• Single-cell atlases of oligodendrocyte lineages ^{7Boggs JM, MBP function (2008)2008 · PMID 18629633Open reference}1

• Novel remyelination promoters in clinical trials ^{7Boggs JM, MBP function (2008)2008 · PMID 18629633Open reference}2

• Gene therapy for leukodystrophies ^{7Boggs JM, MBP function (2008)2008 · PMID 18629633Open reference}3

• Nanoparticle delivery of myelination-promoting drugs ^{7Boggs JM, MBP function (2008)2008 · PMID 18629633Open reference}4

• Age-related demyelination as therapeutic target ^{7Boggs JM, MBP function (2008)2008 · PMID 18629633Open reference}5

Cross-Linked Pathways

• White matter degeneration

• Axonal degeneration

• Oligodendrocyte function

• Neuroinflammation

See Also

• multiple sclerosis

• Alzheimer’s disease

• Parkinson’s disease

• amyotrophic lateral sclerosis

• MBP

• PLP

• MYRF

• White matter degeneration

• Axonal degeneration

• Neuroinflammation

External Links

• PubMed

• KEGG Pathways

Recent Research Updates (2024-2026)

This section highlights recent publications relevant to this mechanism.

• Neuromodulatory role and therapeutic potential of N 6 -methyladenosine RNA methylation in neurodegenerative diseases. (2026 Jun 1) - Neural regeneration research

• Platelet concentrate-derived extracellular vesicles promote adult hippocampal neurogenesis. (2026 May) - Biomaterials

• Neuronal TLR4 upregulation activates the cGAS-STING pathway to induce ferroptosis in EAE mice. (2026 Apr 1) - International immunopharmacology

• Human Myelin Spheres for in Vitro Oligodendrocyte Maturation, Myelination and Neurological Disease Modeling. (2026 Apr) - Stem cell reviews and reports

• Recent Updates on Lipid Landscapes in Neonatal and Adult Neurological Disorders: Advancing Mass Spectrometry and Lipidomics for Disease Insight: A Systematic Review. (2026 Mar 11) - CNS & neurological disorders drug targets